Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOTOX in moderate COPD
NCT06003049Phase 2Completed
- Start
- Oct 2023
- Primary completion
- Apr 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of botulinum toxin type A in chronic obstructive pulmonary disease (COPD). Started Oct 2023; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT06003049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06003049.